微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.85% | -79.12% | -17.48% | 103/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 1.03% | -68.4% | 10.75% | 94/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.93% | -58.11% | -80.79% | 85/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.84% | 12.3% | 18.92% | 60/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 4.07% | 12.74% | 24.85% | 73/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.26% | 29.37% | 46.85% | 57/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.22% | 60.87% | -48.49% | 53/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.31% | -42.91% | 19.39% | 69/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.61% | -51.15% | 43.25% | 85/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.52% | -59.74% | 82.61% | 75/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.38% | -57.67% | -81.72% | 74/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 7.55% | 169.64% | 2.17% | 54/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 7.39% | 111.14% | 18.05% | 51/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.26% | 192.52% | 92.02% | 33/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.26% | 121.77% | 16.43% | 32/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.8% | 120.96% | -20% | 90/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 3.5% | -30.56% | 63.55% | 90/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.14% | -46.9% | 45.58% | 96/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.47% | -40% | 111% | 79/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -13.36% | -730.19% | -365.08% | 121/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 5.04% | -52.36% | 25.06% | 70/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.03% | -24.25% | 64.49% | 64/158 | 4.23% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.45% | 0.82% | 15.57% | 42/158 | 2.2% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.12% | -65.92% | -79.96% | 107/158 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.58% | 77.82% | 98.87% | 32/158 | 7.53% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.32% | 41.11% | 118.93% | 44/158 | 5% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.43% | 30.65% | -60.93% | 46/158 | 2.43% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.22% | -24.88% | 4.54% | 76/158 | 7.17% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.95% | 7.21% | 57.82% | 56/158 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.77% | -8.94% | 102.69% | 60/158 | 4.64% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.86% | -25% | -77.54% | 59/158 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.28% | -20.99% | 49.19% | 62/158 | 9.68% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.55% | -25.7% | 34.06% | 60/158 | 8.34% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.14% | -12.66% | 66.94% | 60/158 | 5.62% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.48% | -20.77% | -76.34% | 35/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 10.48% | -23.39% | 40.29% | 53/158 | 6.22% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 7.47% | -27.55% | 57.59% | 39/158 | 5.64% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.74% | -34.62% | 51.44% | 40/158 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.13% | -2.8% | -77.12% | 26/158 | 2.69% | 贝达药业 | 16.78% | 行业排名> |